Treatment and outcome after hip fracture for patients on oral anticoagulation

Alexander Wilton1, Ayman Sorial1, Tanzeelah Jamadar1

  • 1North West Anglia Foundation Trust, Peterborough, United Kingdom.

Injury
|December 6, 2024
PubMed

Insights

Hip fracture patients on anticoagulation, including direct oral anticoagulants (DOAC), can safely undergo surgery. Current management policies ensure no increased risk of complications or mortality, despite slight delays in theatre timing.

Area of Science:

  • Orthopedic Surgery
  • Geriatric Medicine
  • Pharmacology

Background:

  • Increasing prevalence of hip fracture patients on oral anticoagulation, including DOAC.
  • Uncertainty regarding optimal surgical timing and complication rates in these patients.

Purpose of the Study:

  • To compare treatment and outcomes for hip fracture patients taking anticoagulation versus those not on anticoagulation.
  • To evaluate the safety of current surgical timing policies for hip fracture patients on anticoagulation.

Main Methods:

  • Retrospective analysis of 3,707 hip fracture patients over seven years.
  • Comparison of patient demographics, comorbidities, and perioperative outcomes based on anticoagulation status (warfarin, DOAC, none).

Main Results:

  • Significant increase in DOAC use (1.4% to 11.4%) and slight decrease in warfarin use (6.1% to 4.7%) over the study period.
  • Patients on anticoagulation were older and more likely to have atrial fibrillation.
  • Increased delay to theatre (37.9-39.5 hours) for anticoagulated patients compared to non-anticoagulated patients (31.1 hours).
  • No significant differences observed in transfusion rates, wound complications, post-operative hemoglobin, or 30-day mortality.

Conclusions:

  • Current management policies for hip fracture surgery in patients on oral anticoagulation are safe.
  • Perioperative outcomes, including mortality and complications, are not adversely affected by anticoagulation status.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
707
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
1